HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

What Makes Eravacycline a Unique Antibiotic?

Patrick Horn, MD, PhD, explains why eravacycline is a unique antibiotic and how it stands up against many different types of pathogens, including those that are multidrug-resistant.

Patrick Horn, MD, PhD, chief medical officer at Tetraphase Pharmaceuticals explains why eravacycline is a unique antibiotic and how it stands up against many different types of pathogens, including those that are multidrug-resistant.

Related Content:

ID WeekVideosANTIBIOTICSPREVENTIONMRSAConferences
Considering Criteria for Admission for Skin and Soft Tissue Infections
FDA Approves First-Ever Fecal Microbiota, RBX2660, for C Difficile Recurrence
C difficile Awareness Month: Breakthroughs and Setbacks